BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 2, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Researchers find that 3D-printed tissues could help repair brain injuries

Oct. 18, 2023
By Shani Alexander
Researchers have for the first time used human neural stem cells to print 3D brain tissues that mimic the architecture of the brain’s outer layer, the cerebral cortex. This breakthrough technique, developed by a team from the U.K.’s University of Oxford, could one day be used to provide tailored repairs to the millions of people who suffer from severe brain injuries, for which there is no effective treatment.
Read More
Adiuvo wound care
Patents

Adiuvo develops digital assistant for wound triaging and treatment recommendations

Oct. 18, 2023
By Simon Kerton
Geethanjali Radhakrishnan, founder and managing director of Chennai, India-based Adiuvo Diagnostics Pvt. Ltd. reported filing for patent protection for a digital assistant for wound triaging and treatment recommendations.
Read More

Appointments and advancements for Oct. 18, 2023

Oct. 18, 2023
New hires and promotions in the med-tech industry, including: Rockwell Medical.
Read More

Financings for Oct. 18, 2023

Oct. 18, 2023
Med-tech firms raising money in public or private financings, including: Infobionic, Variantyx.
Read More

In the clinic for Oct. 18, 2023

Oct. 18, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mainz Biomed, Phenomix Sciences, Sequana Medical, Synchrony Medical.
Read More

Other news to note for Oct. 18, 2023

Oct. 18, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellarity, Lifecore Biomedical, Microbot, SHL Medical, Vuze.
Read More

Regulatory actions for Oct. 18, 2023

Oct. 18, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Praxis Medical, Seastar Medical, Telesair, Vyspine.
Read More

Regulatory actions for Oct. 17, 2023

Oct. 17, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Flobio, GE Healthcare, Werfen.
Read More

Other news to note for Oct. 17, 2023

Oct. 17, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aidoc, Aimil, Bayer, Cardio Diagnostics, Concertai, Evidation, Gleamer, Grail, Halo Precision Diagnostics, Odysight.ai, Oncotech, Optellum, Synerfuse, Terarecon.
Read More

In the clinic for Oct. 17, 2023

Oct. 17, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Microbot Medical, Rendever.
Read More
Previous 1 2 … 563 564 565 566 567 568 569 570 571 … 10249 10250 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • Antibodies attacking cancer cell

    ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

    BioWorld
    Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing